Filana Therapeutics Inc.

FLNA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.62

-$0.04 (-5.78%)

At close: Oct 30, 2026, 4:00 PM ET

$0.62

$0.00 (+0.42%)

Pre-market: Nov 2, 2026, 9:22 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 30, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024
Net Income	-55.35M	-46.75M	-61.81M	-78.94M	-55.54M	-27.94M
Depreciation & Amortization	1.02M	718K	611K	739K	519K	259K
Stock-Based Compensation	4.4M	4.4M	10.15M	11.35M	11.35M	5.61M
Other Working Capital	4.69M	4.36M	8.1M	15.09M	9.01M	4.09M
Other Non-Cash Items	14.61M	10.6M	5.23M	5.23M	n/a	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	4.16M	3.73M	-33M	-29.27M	-35.89M	3.78M
Operating Cash Flow	-31.16M	-27.31M	-78.82M	-90.9M	-79.56M	-18.3M
Capital Expenditures	-602K	-581K	-137K	-74K	-74K	-17K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-602K	-581K	-137K	-74K	-74K	-17K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-16K	n/a	918K	918K	918K	n/a
Financial Cash Flow	-255K	-239K	1.01M	1.01M	918K	n/a
Net Cash Flow	-32.02M	-28.13M	-77.95M	-89.96M	-78.72M	-18.31M
Free Cash Flow	-31.76M	-27.89M	-78.96M	-90.97M	-79.64M	-18.31M
Adj. Free Cash Flow	-36.16M	-32.29M	-89.11M	-102.32M	-90.99M	-23.92M
Maintenance CapEx	-468K	-504K	-154K	n/a	n/a	n/a
Growth CapEx	-134K	-134K	n/a	n/a	n/a	n/a
Owner Earnings	-31.63M	-89.07M	-97.27M	n/a	n/a	n/a